Analysts at J.P. Morgan, this morning, issued a Neutral rating on shares of Kindred Healthcare (KND), as well as established an $18 price target.
According J.P. Morgan, one of the major risks moving forward is the "further deterioration in state tax revenues resulting in further Medicaid pressure," which would inhibit the ability of the company to meet Street estimates.
Kindred Healthcare, Inc. operates as a healthcare services company in the United States. It operates in three divisions: Hospital, Health Services, and Rehabilitation.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in